Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
129.1 USD | +0.23% | -1.42% | +18.20% |
05:02pm | Merck: encouraging results in gastric cancer | CF |
05-01 | Merck Says Keytruda Meets Primary Endpoint in Late-Stage Gastric Cancer Trial | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.20% | 326B | |
+29.88% | 699B | |
+25.07% | 571B | |
-4.64% | 364B | |
+2.90% | 286B | |
+14.68% | 236B | |
+4.71% | 198B | |
-12.43% | 194B | |
-3.18% | 154B | |
-4.45% | 149B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Merck : Takes $170 Million Hit From Scrapped COVID-19 Drug